News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

Recent Headlines

in Local

Scholarship Program Announced

Dennis Daugaard

Workforce development continues to be a critical issue in South Dakota as employers struggle to find qualified workers to fill skilled positions.

in Local

Ag Property Taxes On Legislative Agenda

state capitol pierre

The South Dakota legislature will have to again deal with property taxes on ag land.

in Local

Water Project Still Short On Funds

L&C water 102212

The just passed federal budget bill includes more money for rural water projects, but no dollars specifically for the three…

in Local

Details Of Omnibus Bill Coming Out

Kristi Noem 20513

The one point one trillion dollar, seventeen hundred page omnibus spending bill passed by Congress last week has lots of details, which are starting to come out.

in Local

Group Wants More Medical Marijuana

marijuana

A group of Iowans announced a campaign at the state capitol dedicated to promoting regulated access to medical marijuana for patients suffering from a variety of medical conditions.